Tackling Coronavirus: The role of Roquette’s KLEPTOSE® HPβCD in the fight against COVID-19 – an expert video
Hydroxypropyl β-cyclodextrin (HPβCD) has been shown to be effective as solubilizing and stabilizing agents in vaccines, monoclonal antibodies, and oral formulations.
Watch our expert video, featuring Pharma and BioPharma Scientists – Dr. Foo Wen Chin and Dr. Peng Tao – who explain how Roquette’s KLEPTOSE® HPβCD may be used to support the efforts of the scientific and pharmaceutical communities looking to develop drugs for the treatment and prevention of new emerging viruses, such as the coronavirus. Here, they discuss various treatment strategies and the potential role of cyclodextrins as an excipient and adjuvant.
For more information on Roquette’s KLEPTOSE® HPBCD, please visit: https://www.roquette.com/innovation-hub
To read Roquette’s position paper on the role of Cyclodextrins may help in the treatment and prevention of COVID-19, please visit: Combating Coronavirus: Key Role of Cyclodextrins in Treatment and Prevention or https://www.roquette.com/innovation-hub/expert-opinion/kleptose-combating-coronavirus-key-role-of-cyclodextrins-in-treatment-and-prevention